Research Article

High Membranous Expression of Fatty Acid Transport Protein 4 Is Associated with Tumorigenesis and Tumor Progression in Clear Cell Renal Cell Carcinoma

Table 2

CD36, FATP4, and ACSL1 expressions in RCC cases.

CharacteristicsCD36 (%)FATP4 (%)ACSL1 (%)
High ()Low () valueHigh ()Low () valueHigh ()Low () value

Age
 Low (<60 yr)42 (56.8)60 (56.6)0.98443 (50.6)59 (62.1)0.12040 (55.6)62 (57.4)0.806
 High (≥60 yr)32 (43.2)46 (43.4)42 (49.4)36 (37.9)32 (44.4)46 (42.6)
Gender
 Male52 (70.3)75 (70.8)0.94454 (63.5)73 (76.8)0.0544 (61.1)83 (76.9)0.023
 Female22 (29.7)31 (29.2)31 (36.5)22 (23.2)28 (38.9)25 (23.1)
Grade
 Low12 (16.2)22 (20.8)0.44413 (15.3)21 (22.1)0.24412 (16.7)22 (20.4)0.534
 High62 (83.8)84 (79.2)72 (84.7)74 (77.9)60 (83.3)86 (79.6)
TNM stage
 Low (I, II)58 (78.4)87 (82.1)0.53763 (74.1)82 (86.3)0.03955 (76.4)90 (83.3)0.249
 High (III, IV)16 (21.6)19 (17.9)22 (25.9)13 (13.7)17 (23.6)18 (16.7)
Metastasis
 Absent71 (95.9)99 (93.4)0.52980 (94.1)90 (94.7)1.00067 (93.1)103 (95.4)0.524
 Present3 (4.1)7 (6.6)5 (5.9)5 (5.3)5 (6.9)5 (4.6)
Tumor necrosis
 Absent65 (87.8)95 (89.6)0.70870 (82.4)90 (94.7)0.00964 (88.9)96 (88.9)1.000
 Present9 (12.2)11 (10.4)15 (17.6)5 (5.3)8 (11.1)12 (11.1)
Sarcomatoid feature
 Absent70 (94.6)101 (95.3)1.00081 (95.3)90 (94.7)1.00070 (97.2)101 (93.5)0.319
 Present4 (5.4)5 (4.7)4 (4.7)5 (5.3)2 (2.8)7 (6.5)
Recurrence
 Absent61 (82.4)86 (81.1)0.82464 (75.3)83 (87.4)0.03761 (84.7)86 (79.6)0.387
 Present13 (17.6)20 (18.9)21 (24.7)12 (12.6)11 (15.3)22 (20.4)

RCC: clear cell renal cell carcinoma; TNM: tumor-node-metastasis.